Research & Development
Policy & Regulation
Trends & Finance
Mergers & Acquisitions
Agilent to sell Resolution Bioscience to Exact Sciences
Agilent Technologies has announced that it is selling Resolution Bioscience, its cancer testing business, to Exact Sciences for an undisclosed sum.
September 12, 2023
LabGenomics USA acquires QDx Pathology
In a strategic move to expand its North American market, LabGenomics USA, a subsidiary of South Korea-based LabGenomics, has acquired diagnostic and molecular service provider QDx Pathology.
September 6, 2023
Danaher to acquire Abcam for $5.7B
Science and medical technology firm Danaher announced Monday that it has entered into an agreement to acquire Abcam, a Cambridge, U.K.-based supplier of antibodies, reagents, biomarkers, and assays.
August 29, 2023
Agilent closes $550M liquid biopsy unit after failing to find path to profits
When Agilent bought Resolution, it identified the company’s presence in fast-growing NGS technologies for precision oncology as a way to expand its addressable market; rather than realizing that opportunity, Agilent has ended up cutting its losses.
August 18, 2023
New Day Diagnostics inks $12M deal to buy Epigenomics’ cancer technology
Epigenomics has agreed to sell “substantially all” of its assets to New Day Diagnostics, a developer of tests for the early detection and monitoring of disease that merged with EDP Biotech earlier this month.
July 31, 2023
Vector Laboratories buys Quanta Bio for polyethylene glycol technology
Single molecular weight, discrete-length PEG chains such as Quanta’s dPEG products can simplify peptide analysis compared to other products that contain a range of PEG chain lengths and molecular weights.
July 24, 2023
Applied DNA buys Spindle Biotech to improve mRNA production offering
New York-based Applied DNA will integrate its LinearDNA platform and Spindle’s RNAP to make LineaIVT, a platform that it claims will address challenges facing manufacturers of mRNA vaccines and therapies.
July 20, 2023
Novacyt to purchase Yourgene for $21.2M
In a statement, the Camberley, U.K.-based Novacyt said that the acquisition of Yourgene will diversify and expand its testing offerings and geographic footprint, a strategy in part prompted by falling demand for Novacyt’s COVID-19 testing services.
July 11, 2023
FTC mulls changes to company merger rules
The proposed rule change would amend the Hart-Scott-Rodino (HSR) form and instructions, the first time in 45 years that the agencies will perform a top-to-bottom review of the form.
June 29, 2023
Intus Bio buys Pattern Genomics to enhance microbiome analysis capabilities
Intus Bio sees the integration enhancing the platform with machine-learning tools for biomarker discovery and patient stratification, supporting the firm’s work in turning microbiome technologies into practical medical and pharmaceutical applications.
June 29, 2023
Genomics AI firm Genomenon acquires Boston Genetics
An expanded genomic interpretation team enabled by the acquisition supports its offerings for clinical diagnostic and pharmaceutical drug development programs, Genomenon said.
June 27, 2023
Bio-Techne to acquire Swiss spatial biology firm Lunaphore
Bio-Techne said that it expects to close the deal by the end of September, in the first quarter of its fiscal 2024.
June 22, 2023
Page 1 of 9